Trial Information
WT-1's Role in Leukemogenesis
OBJECTIVES:
- To measure WT1 and VEGF-1 expression in patients with acute promyelocytic leukemia.
OUTLINE: This is a multicenter study.
Patient mRNA samples from diagnosis are analyzed via quantitative PCR to measure WT1 and
VEGF-1 expression.
Inclusion Criteria
DISEASE CHARACTERISTICS:
- Diagnosis of acute promyelocytic leukemia [t(15;17) translocation]
PATIENT CHARACTERISTICS:
- Not specified
PRIOR CONCURRENT THERAPY:
- Not specified
Type of Study:
Observational
Study Design:
N/A
Outcome Measure:
WT1 and VEGF-1 expression
Safety Issue:
No
Principal Investigator
Mustafa M. Moazam, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Akron Children's Hospital
Authority:
United States: Federal Government
Study ID:
CDR0000671471
NCT ID:
NCT01146223
Start Date:
September 2009
Completion Date:
Related Keywords:
- Leukemia
- adult acute promyelocytic leukemia (M3)
- childhood acute promyelocytic leukemia (M3)
- adult acute myeloid leukemia with t(15;17)(q22;q12)
- adult acute myeloid leukemia
- Leukemia
- Leukemia, Promyelocytic, Acute